# CONJUPRI
> **NDA212895** · New Drug Application · Sponsor: CSPC OUYI · Approved 2019-12-19
## Drug
- **FDA Application Number:** NDA212895
- **Application type:** New Drug Application
- **Brand name:** CONJUPRI
- **Generic name:** LEVAMLODIPINE
- **Active ingredients:** LEVAMLODIPINE MALEATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** CSPC OUYI
- **Manufacturer:** CSPC Ouyi Pharmaceutical Co. Ltd
- **First approval:** 2019-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212895)
---
*MORVS · CC0 1.0*